Skip to main navigation Skip to search Skip to main content

Individualizing therapy for pancreatic cancer

  • Emily K. Colvin
  • , David K. Chang
  • , Neil D. Merrett
  • , James G. Kench
  • , Andrew V. Biankin

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

Editorial. See article in J. Gastroenterol. Hepatol. 2008; 23: 1852-1859 The study by Jiang and colleagues in this issue of the Journal of Gastroenterology and Hepatology reports the relationship of neural growth factor (NGF), tyrosine kinase receptor A (TrkA), and perineural invasion in pancreatic cancer (PC). They hypothesize that these molecules may play a key role in perineural invasion, and hence, tumor progression and metastases. As a consequence, they may be clinically useful markers (biomarkers) of poor prognosis and potential targets for the development of novel therapeutic strategies.
Original languageEnglish
Pages (from-to)1779-1782
Number of pages4
JournalJournal of Gastroenterology and Hepatology
Volume23
Issue number12
DOIs
Publication statusPublished - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Individualizing therapy for pancreatic cancer'. Together they form a unique fingerprint.

Cite this